298 related articles for article (PubMed ID: 36371813)
1. Antibody-Dependent Enhancement (ADE) and the role of complement system in disease pathogenesis.
Thomas S; Smatti MK; Ouhtit A; Cyprian FS; Almaslamani MA; Thani AA; Yassine HM
Mol Immunol; 2022 Dec; 152():172-182. PubMed ID: 36371813
[TBL] [Abstract][Full Text] [Related]
2. Multiple Routes of Antibody-Dependent Enhancement of SARS-CoV-2 Infection.
Okuya K; Hattori T; Saito T; Takadate Y; Sasaki M; Furuyama W; Marzi A; Ohiro Y; Konno S; Hattori T; Takada A
Microbiol Spectr; 2022 Apr; 10(2):e0155321. PubMed ID: 35319248
[TBL] [Abstract][Full Text] [Related]
3. A Review: Understanding Molecular Mechanisms of Antibody-Dependent Enhancement in Viral Infections.
Sawant J; Patil A; Kurle S
Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515055
[TBL] [Abstract][Full Text] [Related]
4. The role of IgG Fc receptors in antibody-dependent enhancement.
Bournazos S; Gupta A; Ravetch JV
Nat Rev Immunol; 2020 Oct; 20(10):633-643. PubMed ID: 32782358
[TBL] [Abstract][Full Text] [Related]
5. A complement component C1q-mediated mechanism of antibody-dependent enhancement of Ebola virus infection.
Furuyama W; Nanbo A; Maruyama J; Marzi A; Takada A
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008602. PubMed ID: 32886656
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
Front Immunol; 2018; 9():597. PubMed ID: 29740424
[TBL] [Abstract][Full Text] [Related]
7.
van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
[TBL] [Abstract][Full Text] [Related]
8. Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies.
Ricke DO
Front Immunol; 2021; 12():640093. PubMed ID: 33717193
[TBL] [Abstract][Full Text] [Related]
9. Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan Antibodies.
Ziganshina MM; Shilova NV; Khalturina EO; Dolgushina NV; V Borisevich S; Yarotskaya EL; Bovin NV; Sukhikh GT
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515270
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.
von Kietzell K; Pozzuto T; Heilbronn R; Grössl T; Fechner H; Weger S
J Virol; 2014 Jul; 88(14):8102-15. PubMed ID: 24807719
[TBL] [Abstract][Full Text] [Related]
11. Antibody-Dependent Enhancement: ″Evil″ Antibodies Favorable for Viral Infections.
Yang X; Zhang X; Zhao X; Yuan M; Zhang K; Dai J; Guan X; Qiu HJ; Li Y
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016361
[TBL] [Abstract][Full Text] [Related]
12. C1q modulation of antibody-dependent enhancement of dengue virus infection in human myeloid cell lines is dependent on cell type and antibody specificity.
Byrne AB; Bonnin FA; López EL; Polack FP; Talarico LB
Microbes Infect; 2024 Jun; ():105378. PubMed ID: 38880233
[TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications.
Takada A; Kawaoka Y
Rev Med Virol; 2003; 13(6):387-98. PubMed ID: 14625886
[TBL] [Abstract][Full Text] [Related]
14. Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.
van Erp EA; Luytjes W; Ferwerda G; van Kasteren PB
Front Immunol; 2019; 10():548. PubMed ID: 30967872
[TBL] [Abstract][Full Text] [Related]
15. Non-neutralizing antibodies: Deleterious or propitious during SARS-CoV-2 infection?
Zanella I; Degli Antoni M; Marchese V; Castelli F; Quiros-Roldan E
Int Immunopharmacol; 2022 Sep; 110():108943. PubMed ID: 35753123
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection.
Narayan R; Tripathi S
Front Cell Infect Microbiol; 2020; 10():580096. PubMed ID: 33123500
[TBL] [Abstract][Full Text] [Related]
17. Antibody-Dependent Enhancement of SARS-CoV-2 Infection of Human Immune Cells: In Vitro Assessment Provides Insight in COVID-19 Pathogenesis.
Shen XR; Li Q; Li HL; Wang X; Wang Q; Zheng XS; Geng R; Zhang YL; Li B; Jiang RD; Liu MQ; Zhu Y; Zhang W; Yang XL; Peng K; Zhou P
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960752
[TBL] [Abstract][Full Text] [Related]
18. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.
Wan Y; Shang J; Sun S; Tai W; Chen J; Geng Q; He L; Chen Y; Wu J; Shi Z; Zhou Y; Du L; Li F
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826992
[TBL] [Abstract][Full Text] [Related]
19. Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus.
Mehlhop E; Nelson S; Jost CA; Gorlatov S; Johnson S; Fremont DH; Diamond MS; Pierson TC
Cell Host Microbe; 2009 Oct; 6(4):381-91. PubMed ID: 19837377
[TBL] [Abstract][Full Text] [Related]
20. Neuraminidase augments Fc gamma receptor II-mediated antibody-dependent enhancement of dengue virus infection.
Mady BJ; Kurane I; Erbe DV; Fanger MW; Ennis FA
J Gen Virol; 1993 May; 74 ( Pt 5)():839-44. PubMed ID: 8492089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
